(Q38285779)

1 September 2017

1 reference

title

Vitamin D as a novel therapy in inflammatory bowel disease: new hope or false dawn? (English)

1 reference

inflammatory bowel diseases

1 September 2017

0 references

vitamin D

0 references

author name string

Maria O'Sullivan

series ordinal

1

1 reference

1 September 2017

10 December 2014

1 reference

Proceedings of the Nutrition Society

1 September 2017

1 reference

1 September 2017

74

1 reference

1 September 2017

1

1 reference

1 September 2017

5-12

1 reference

Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice

1 September 2017

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

The vitamin D receptor turns off chronically activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Optimal Serum 25-Hydroxyvitamin D Levels for Multiple Health Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Predicting the Crohn's disease activity index from the Harvey-Bradshaw Index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Predicted 25(OH)D score and colorectal cancer risk according to vitamin D receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Epidemiology of vitamin D and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Association between residences in U.S. northern latitudes and rheumatoid arthritis: A spatial analysis of the Nurses' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

UVA Irradiation of Human Skin Vasodilates Arterial Vasculature and Lowers Blood Pressure Independently of Nitric Oxide Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Determinants of plasma 25-hydroxyvitamin D and development of prediction models in three US cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Low exposure to sunlight is a risk factor for Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Higher predicted vitamin D status is associated with reduced risk of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Review article: vitamin D and inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Geographical variation and incidence of inflammatory bowel disease among US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Correction of Low Vitamin D Improves Fatigue: Effect of Correction of Low Vitamin D in Fatigue Study (EViDiF Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Mechanisms underlying the effect of vitamin D on the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Serum 25-hydroxyvitamin D and muscle atrophy in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Chronic fatigue is more prevalent in patients with inflammatory bowel disease than in healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Objectively measured muscle fatigue in Crohn's disease: correlation with self-reported fatigue and associated factors for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Epidemiology of vitamin D and colorectal cancer: casual or causal link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Review article: vitamin D and inflammatory bowel disease--established concepts and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D: new roles and therapeutic potential in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D3 treatment of Crohn's disease patients increases stimulated T cell IL-6 production and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D status and cytokine levels in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Gut microbiota in older subjects: variation, health consequences and dietary intervention prospects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

The microbiome in inflammatory bowel disease and its modulation as a therapeutic manoeuvre

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Review article: Osteoporosis and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Symposium on 'The challenge of translating nutrition research into public health nutrition'. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease'. Nutrition in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Geoepidemiology of autoimmune rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D, multiple sclerosis and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D and multiple sclerosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN D3IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS: PRESENCE IN MONOCYTES AND INDUCTION IN T LYMPHOCYTES FOLLOWING ACTIVATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

1,25-Dihydroxyvitamin D3Receptors in Human Leukocytes

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

Etiopathogenesis of inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

The vitamin D epidemic and its health consequences

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

Active Crohn's disease is associated with low vitamin D levels

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

Therapeutic effect of vitamin d supplementation in a pilot study of Crohn's patients

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier

1 reference

https://api.crossref.org/works/10.1017%2FS0029665114001621

7 January 2021

10.1017/S0029665114001621

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25490986